Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Celiac Disease Market Forecast: Value Set To Climb From $0.86 Billion To $1.26 Billion#_x000D_
The celiac disease market has experienced rapid expansion in recent years. It is projected to increase from $0.78 billion in 2025 to $0.87 billion in 2026, at a compound annual growth rate (CAGR) of 10.3%. This historical growth can be attributed to heightened autoimmune disease awareness, advancements in diagnostics, broader adoption of dietary management, specialized hospital gastroenterology care, and active patient advocacy._x000D_
_x000D_
The celiac disease market size is predicted to undergo significant expansion in the upcoming years. It is projected to climb to $1.27 billion in 2030, showing a compound annual growth rate (CAGR) of 10.0%. This anticipated growth during the forecast period stems from developments in novel drugs, innovations in gluten-free foods, personalized dietary plans, early detection programs, and microbiome research. Notable trends for this period include an increasing adoption of gluten-free diets, the rise of packaged gluten-free products, the broadening of drug-based treatments, enhanced disease awareness and diagnosis, and a concentrated focus on microbiome-based therapies._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Celiac Disease Market Demand Drivers Opening New Revenue Streams#_x000D_
The expanding field of personalized medicine is anticipated to propel the celiac disease market forward. This healthcare approach customizes medical care based on an individual’s unique genetic profile, surrounding environment, and lifestyle choices. The rising demand for personalized medicine is driven by the growing accessibility of genetic testing, which facilitates more accurate diagnoses and treatments specifically tailored to individual patient requirements. For celiac disease treatment, the growth of personalized medicine is supportive by enabling precise identification of genetic markers and individual immune responses, thereby leading to more targeted and effective management strategies for each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the FDA authorized 16 personalized therapies in 2023 targeting rare diseases, representing an increase compared to the 6 approved in 2022. Therefore, the advancement of personalized medicine will boost the growth of the celiac disease market._x000D_
_x000D_
#Celiac Disease Market Segment Analysis And Revenue Potential#_x000D_
The celiac disease market covered in this report is segmented – _x000D_
_x000D_
1) By Treatment: Larazotide Acetate, Gluten Free Diet, Other Treatments_x000D_
2) By Route Of Administration: Oral, Parenteral_x000D_
3) By End Users: Hospitals, Homecare, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Larazotide Acetate: Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy_x000D_
2) By Gluten Free Diet: Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages_x000D_
3) By Other Treatments: Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators_x000D_
_x000D_
#Celiac Disease Market Trends Powering Strategic Industry Growth#_x000D_
Major companies in the celiac disease market are prioritizing the development of advanced solutions, such as anti-interleukin-15 (IL-15) antibodies, to alleviate tissue damage by curbing hyperactive immune cell activity. Anti-interleukin-15 (IL-15) antibodies are specialized proteins designed to inhibit the function of the IL-15 cytokine, assisting in the control of immune system activity and inflammation. For instance, in May 2025, Teva Pharmaceutical Industries, an Israel-based pharmaceutical company, announced that the U.S. Food and Drug Administration had granted Fast Track status to TEV-53408, an investigational anti-interleukin-15 (IL-15) antibody. This investigational monoclonal antibody is being developed for individuals with celiac disease who maintain a gluten-free diet. It operates by blocking interleukin-15 (IL-15), a molecule implicated in triggering the immune response that causes intestinal harm in celiac patients. The therapy is currently in a Phase 2a clinical trial to assess its safety and efficacy._x000D_
_x000D_
#Celiac Disease Market Key Players Shaping Industry Direction#_x000D_
Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc. _x000D_
_x000D_
#View The Full Celiac Disease Market Report:#_x000D_
_x000D_
#Celiac Disease Market Regional Breakdown: Where Is Demand Concentrated?#_x000D_
North America was the largest region in the celiac disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model